1 2 3 Vadodara: During the two years of the Covid-19 pandemic, while the world came to a standstill and many were confined to their homes, city-based Devansh Parikh faced a personal challenge. His aunt, a diabetic, was reluctant to visit an ophthalmologist for a retinopathy check-up. This situation became a turning point for Parikh, a recent electrical engineering graduate from Birla Vishvakarma Mahavidyalaya, Vallabh Vidyanagar (Class of 2020).
Motivated by the need for accessible eye care, Parikh began working on a portable fundus imaging device capable of capturing high-quality retinal images and using AI-based analysis to screen for conditions such as diabetic retinopathy , glaucoma, age-related macular degeneration, retinal detachment, and other eye abnormalities. Unlike traditional fundus cameras — often bulky and prohibitively expensive — Parikh's innovation, called Ocellux , is compact, cost-effective, and designed for ease of use. "This device can be integrated into any existing healthcare setup without the need for a technician.
Even general medical practitioners can use it to image the retina with minimal training. The AI software generates instant diagnostic reports," said Parikh, who is also the founder of Vadodara-based MedTech startup Anself Dynamics. Certified by the department for promotion of industry and Internal trade (DPIIT), Anself Dynamics was recently recognized by the India AI Innovation Mission, a flagship initiative of the govt of India.
Out of over 900 applicants, Anself Dynamics was named among the top 30 AI startups shaping the future of healthcare. As part of this recognition, the startup received a Rs 25 lakh grant under the healthcare AI category, presented by Union minister for electronics and information technology Ashwini Vaishnaw in New Delhi. Parikh highlighted the affordability of his innovation.
"While traditional fundus camera systems are priced between Rs 4 lakh and Rs 10 lakh — some going as high as Rs 50 lakh — we are able to manufacture and market Ocellux for under Rs 80,000," he said. Parikh's achievements include winning the MIT Covid-19 Challenge hosted by the Massachusetts Institute of Technology (MIT) in 2020, and securing a $3,000 grant through the regional NSF iCorps programme in Sept 2021. Ocellux's collapsible design allows for easy portability and deployment.
It captures true-colour, high-resolution retinal images, enabling healthcare professionals to detect retinal abnormalities with greater accuracy. In addition to Ocellux, the startup has also developed Slit Pal, a plug-and-play slit lamp imaging system that digitizes anterior and posterior segment examinations. "Slit Pal supports early diabetic eye screening, cataract detection, and enables advanced computational imaging for telemedicine and triaging, improving diagnostic accuracy and helping healthcare providers deliver better outcomes," said Parikh.
Vadodara: During the two years of the Covid-19 pandemic, while the world came to a standstill and many were confined to their homes, city-based Devansh Parikh faced a personal challenge. His aunt, a diabetic, was reluctant to visit an ophthalmologist for a retinopathy check-up. This situation became a turning point for Parikh, a recent electrical engineering graduate from Birla Vishvakarma Mahavidyalaya, Vallabh Vidyanagar (Class of 2020).
Motivated by the need for accessible eye care, Parikh began working on a portable fundus imaging device capable of capturing high-quality retinal images and using AI-based analysis to screen for conditions such as diabetic retinopathy, glaucoma, age-related macular degeneration, retinal detachment, and other eye abnormalities. Unlike traditional fundus cameras — often bulky and prohibitively expensive — Parikh's innovation, called Ocellux, is compact, cost-effective, and designed for ease of use. "This device can be integrated into any existing healthcare setup without the need for a technician.
Even general medical practitioners can use it to image the retina with minimal training. The AI software generates instant diagnostic reports," said Parikh, who is also the founder of Vadodara-based MedTech startup Anself Dynamics. Certified by the department for promotion of industry and Internal trade (DPIIT), Anself Dynamics was recently recognized by the India AI Innovation Mission, a flagship initiative of the govt of India.
Out of over 900 applicants, Anself Dynamics was named among the top 30 AI startups shaping the future of healthcare. As part of this recognition, the startup received a Rs 25 lakh grant under the healthcare AI category, presented by Union minister for electronics and information technology Ashwini Vaishnaw in New Delhi. Parikh highlighted the affordability of his innovation.
"While traditional fundus camera systems are priced between Rs 4 lakh and Rs 10 lakh — some going as high as Rs 50 lakh — we are able to manufacture and market Ocellux for under Rs 80,000," he said. Parikh's achievements include winning the MIT Covid-19 Challenge hosted by the Massachusetts Institute of Technology (MIT) in 2020, and securing a $3,000 grant through the regional NSF iCorps programme in Sept 2021. Ocellux's collapsible design allows for easy portability and deployment.
It captures true-colour, high-resolution retinal images, enabling healthcare professionals to detect retinal abnormalities with greater accuracy. In addition to Ocellux, the startup has also developed Slit Pal, a plug-and-play slit lamp imaging system that digitizes anterior and posterior segment examinations. "Slit Pal supports early diabetic eye screening, cataract detection, and enables advanced computational imaging for telemedicine and triaging, improving diagnostic accuracy and helping healthcare providers deliver better outcomes," said Parikh.
.